Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 2 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MT Pharma from Léglise, company number BE1000033178, closed financial year 2025 with a result of € -33,835 after tax. For that financial year MT Pharma recorded a gross margin of € 116,646 and equity of € -47,942. Compared with financial year 2024, the result moved from € -54,108 to € -33,835. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ -47,942
▼ € 33,835 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -33,835
▲ 37 % less loss than in 2024
Profit after tax over the fiscal year.
€ 9,343
▼ 82% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -87,942.
People and assets in 2025
1
▼ 0.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 80,315
▲ 96% vs 2024
€ 80,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 13,705
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 498,659
▼ 9% vs 2024
€ 44,856 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 137,602
▲ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 13,936
▲ 8% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 37,693 | € 116,646 | ▲ 209% |
| Profit after taxes | € -54,108 | € -33,835 | ▲ € 20,273 |
| Equity | € -14,108 | € -47,942 | ▼ € 33,835 |
| Total debts | € 722,517 | € 745,281 | ▲ 3% |
| Cash | € 52,035 | € 9,343 | ▼ 82% |
| Land & buildings | € 260,103 | € 251,522 | ▼ 3% |
| Retained profit | € -54,108 | € -87,942 | ▼ € 33,835 |
| Bank debt | € 546,274 | € 498,659 | ▼ 9% |
| Balance sheet total | € 708,409 | € 697,338 | ▼ 2% |
| Employees (FTE) | 1.6 | 1 | ▼ 0.6 |
Key figures of MT Pharma, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MT Pharma?
What happened at MT Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 33,835. Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
- DSTM Holding SRL became a director. NBB
- DG Lux Holding SRL became a director. NBB
In short
From € 54,108 loss in 2024 to € 33,835 loss in 2025.
Paid € 472 in corporate taxes since 2024.
On average € 116,600 of value added per employee in 2025.
Management
The stake of DG Lux Holding, DSTM HOLDING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MT PharmaBehind MT Pharma are DSTM Holding SRL and DG Lux Holding SRL. The shares are held by DG Lux Holding (50%) and DSTM HOLDING (50%).
Directors
According to the 2025 annual accounts
since 2023
since 2023
Shareholders
50%
50%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Chemin de Flory Champ 9
6860 Léglise
Rue de la Révision 104
4032 Liège
Active since 1 January 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1000.033.178
- VAT number
- BE 1000.033.178
- Registered office
- Chemin de Flory Champ 9, 6860 Léglise
- Names & denominations
- MT Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 September 2023
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten